1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic and clinical characteristics of the study groupsa
MSA-p IPD Healthy Control P Value No. 27 50 27 Mean age (yr) 64.8 ± 8.6 (47–77) 66.5 ± 6.7 (54–81) 64.7 ± 8.5 (47–77) .521b Male/female ratio 13:14 23:27 11:16 .850c Mean disease duration (yr) 4.7 ± 2.9 7.8 ± 5.0 NA .010d H&Y scale 2.85 ± 0.72 1.95 ± 0.57 NA <.001d No. of patients with asymmetric presentation 17 10 NA <.001c